Description
CEFURONET CV 156 Suspension is an oral antibiotic suspension combining Cefuroxime 125 mg and Clavulanic Acid 31.25 mg per 5 ml. This formulation provides broad-spectrum antibacterial activity by combining a second-generation cephalosporin with a beta-lactamase inhibitor, thereby enhancing efficacy against beta-lactamase-producing bacteria.
Indications:
CEFURONET CV 156 is indicated for the treatment of various bacterial infections, including:
-
Respiratory tract infections (e.g., bronchitis, pneumonia)
-
Urinary tract infections
-
Skin and soft tissue infections
-
Otitis media
-
Pharyngitis and tonsillitis
Dosage and Administration:
The dosage of CEFURONET CV 156 is determined based on the patient’s age, weight, and the severity of the infection. It is essential to follow the dosing instructions provided by a healthcare professional. The suspension should be prepared by adding the specified amount of water to the powder, as directed in the product’s instructions.
Contraindications:
-
Known hypersensitivity to Cefuroxime axetil, Clavulanic Acid, or any component of the formulation
Precautions:
-
Use with caution in patients with a history of gastrointestinal disease, particularly colitis
-
Monitor renal function in patients with renal impairment
Side Effects:
Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Allergic reactions, including rash and anaphylaxis, may occur. If any severe side effects are observed, discontinue use and consult a healthcare professional immediately.
Storage:
Store the reconstituted suspension in a refrigerator (2°C to 8°C) and use within the time frame specified in the product’s instructions. Do not freeze. Keep out of reach of children.
Reviews
There are no reviews yet.